Journal of the Association for Information Science and Technology ( JASIST)ĭata Analysis and Knowledge Discovery (A Chinese Core Journal, CCF-C Rank) Information Processing and Management ( IPM) Editorial Board Member ACM Transactions on Information Systems ( TOIS) - Associate EditorĪCM Transactions on Asian and Low-Resource Language Information Processing ( TALLIP) - Associate Editor.We have set up a Github account, WHUIR, for releasing the implementations relevant to our reseach works Three full papers have been accepted by SIGIR 2023! Two full paper has been accepted by WSDM 2024! One AAAI and one ICDE paper have been accepted! Wuhan University, China Email: cllee whu edu cn ![]() Zhou, J., Liu, M., Sun, H., Feng, Y., Xu, L., Chan, A.W.H., Tong, J.H., Wong, J., Chong, C.C.N., Lai, P.B.S., Wang, H.K., Tsang, S.W., Goodwin, T., Liu, R., Huang, L., Chen, Z.Chenliang LI - Wuhan University 中文版 Chenliang Li Professor.Biochemistry, Genetics and Molecular Biology, (miscellaneous) 11/254. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. Targeting Monocyte-intrinsic Enhancer Reprogramming Improves Immunotherapy Efficacy in Hepatocellular Carcinoma. Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade. Enhancer reprogramming by selective HDAC8 inhibition potentiates T cell infiltration and durable antitumor efficacy of PD-L1 blockade. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis. Different orthotopic mouse models including breast cancer, melanoma, colon cancer and liver cancer models as well as related patient specimens will be integrated. Zhou’s current research interests are focusing on studying the neuroimmunomodulations and immunometabolism in cancer metastasis and cancer immunotherapy, using integrative platforms of high-dimensional flow cytometry, immune cell tracing methods, cellular metabolomics neurotropic virus tracing, optogenetic and chemogenetic manipulations, and the latest single-cell sequencing technologies. She has received academic awards including recognitions from the American Association of Immunologists (AAI), United European Gastroenterology (UEG) and AstraZeneca. Zhou has published in international journals including Science Translational Medicine, Gut, Journal of Clinical Investigation, Cancer Research, Nature Communications, Nature Microbiology and served as co-inventor of two U.S. Alfred Cheng’s lab, School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK) and was promoted to Research Assistant Professor in 2018 and Assistant Professor in 2022. She continued her research as a postdoctoral fellow in Prof. degree in Microbiology from the AIDS Institute, Department of Microbiology, the University of Hong Kong (HKU) in 2013 and received the Awards for Outstanding Research Postgraduate Student (HKU). Room 509A, 3/F, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, CUHK Featured Interviews and Column ArticlesĮmail: This email address is being protected from spambots.SBS Postgraduate Research Day (Restricted download area). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |